Lantern was granted these rare pediatric disease designations in: malignant rhabdoid tumors (MRT), rhabdomyosarcoma (RMS), and hepatoblastoma. Lantern's investigational drug candidate, LP-184, has ...

Lantern Pharma has won a trio of rare-pediatric-disease designations from the Food and Drug Administration for its investigational drug candidate LP-184 in multiple ultra-rare children's cancers.

Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence ("AI") company developing targeted and transformative cancer ...

Throughout the McFarland’s ordeal, the Children’s Cancer Network became the family’s ally.

An Upstate mom shares the uphill battle to recovery from her daughter's cancer and is grateful for where they are now. Kylie Jeter, 3, is an energetic little girl, but just a few years ago, it was a ...

James' son Hudson, who is two next month, was diagnosed with Hepatoblastoma, a rare liver cancer, in May 2024 which was discovered during a routine vaccination appointment while the family were living ...

A young boy has enjoyed his first day at school after being diagnosed with cancer when he was just two years old ...

A four-year-old boy, Hugo was diagnosed with a form of cancer back in October 2022 and his mother Jasmine Sarll has spoken of the difficult time.

THEY TOLD ME THAT THEY FOUND A LESIONS ON HER LIVER. THEY THEN WENT TO MUSK IN CHARLESTON, WHERE THEY DIAGNOSED KYLIE WITH ...